Summary:
Fentanyl is a synthetic opioid that can be delivered through a transdermal therapeutic system (TTS). The aim of this study was to assess the efficacy of fentanyl TTS in treating oral mucositis pain in 75 adult hematopoietic stem cell transplant (HSCT) patients. The analysis was based on 62 patients who developed mucositis. Pain control was assessed by the patients using a visual analogue scale (VAS) from day 0 to day +33 after HSCT. Fentanyl TTS was administered at the patient's request. In all, 20 patients did not require fentanyl (group A). The first 22 patients asking for the patch received fentanyl 25 μg/h (group B) and the subsequent 20 patients received 50 μg/h (group C). There were no significant differences in pain relief between groups B and C. The expected effect of a decrease in mean pain score (mean of the VAS scores of all of the patients in the same group each day) following the application of fentanyl TTS was not noted. We can conclude that fentanyl TTS at the doses used in this study may not adequately relieve oral mucositis pain.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Eisen D, Essell J, Broun ER . Oral cavity complications of bone marrow transplantation. Semin Cutan Med Surg 1997; 16: 265–272.
Pillitteri LC, Clark RE . Comparison of a patient-controlled analgesia system with continuous infusion for administration of diamorphine for mucositis. Bone Marrow Transplant 1998; 22: 495–498.
Jeal W, Benfield P . Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control. Drugs 1997; 53: 109–138.
Donner B, Zenz M, Tryba M, Strumpf M . Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. Pain 1996; 64: 527–534.
Gourlay GK . Treatment of cancer pain with transdermal fentanyl. Lancet Oncol 2001; 2: 165–172.
Grond S, Zech D, Lehmann KA et al. Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region. Pain 1997; 69: 191–198.
Donner B, Zenz M, Strumpf M, Raber M . Long-term treatment of cancer pain with transdermal fentanyl. J Pain Symptom Manage 1998; 15: 168–175.
Sloan PA, Moulin DE, Hays H . A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain. J Pain Symptom Manage 1998; 16: 102–111.
Allan L, Hays H, Jensen NH et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001; 322: 1154–1158.
Parulekar W, Mackenzie R, Bjarnason G, Jordan RC . Scoring oral mucositis. Oral Oncol 1998; 34: 63–71.
Scott J, Huskisson EC . Graphic representation of pain. Pain 1976; 2: 175–184.
Demarosi F, Soligo D, Lodi G et al. Prospective evaluation of transdermal fentanyl in symptomatic treatment of oral mucositis in patients undergoing bone marrow transplantation. Bone Marrow Transplant 2003; 31 (Suppl.): 220 (abstr. 752).
Strupp C, Sudhoff T, Germing U et al. Transdermal fentanyl during high-dose chemotherapy and autologous stem cell support. Oncol Rep 2000; 7: 659–661.
Chapman CR, Donaldson GW, Jacobson RC, Hautman B . Differences among patients in opioid self-administration during bone marrow transplantation. Pain 1997; 71: 213–223.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Demarosi, F., Lodi, G., Soligo, D. et al. Transdermal fentanyl in HSCT patients: an open trial using transdermal fentanyl for the treatment of oral mucositis pain. Bone Marrow Transplant 33, 1247–1251 (2004). https://doi.org/10.1038/sj.bmt.1704515
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704515
Keywords
This article is cited by
-
Use of a buprenorphine-based pain management protocol is associated with reduced opioid requirements and pain on swallowing in oral mucositis: a retrospective cohort study
Supportive Care in Cancer (2022)
-
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines
Supportive Care in Cancer (2020)
-
Prevention and treatment of oral mucositis pain following cancer therapy
Drugs & Therapy Perspectives (2018)
-
Efficacy and safety of transdermal fentanyl for the treatment of oral mucositis pain caused by chemoradiotherapy in patients with esophageal squamous cell carcinoma
Supportive Care in Cancer (2015)
-
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients
Supportive Care in Cancer (2013)